Arunjyoti Bio Ventures Limited has issued an important regulatory disclosure to BSE Limited regarding unsolicited messages being circulated about the company's scrip. The formal communication, dated April 13, 2026, was made under Regulation 30(11) of SEBI (LODR) Regulations, 2015.

Regulatory Disclosure Details

The company has been informed about instances of unsolicited messages being circulated in relation to Arunjyoti Bio Ventures Limited's scrip. This disclosure represents the company's proactive approach to maintaining transparency and protecting investor interests in compliance with securities regulations.

Investor Advisory

In response to these developments, Arunjyoti Bio Ventures Limited has issued a clear advisory to investors. The company has specifically advised investors to take due care and caution while dealing in shares of the company. This precautionary measure aims to protect shareholders from potential misinformation or manipulative activities that may affect trading decisions.

Management Authorization

The disclosure was formally authorized and signed by Pabbathi Badari Narayana Murthy, who serves as the Whole-Time Director of the company. His Director Identification Number (DIN) is 01445523, and the document bears his digital signature along with the official company stamp.

Regulatory Compliance

This disclosure demonstrates the company's commitment to maintaining regulatory compliance and transparency standards as mandated by SEBI regulations. The timely communication to BSE Limited reflects the company's adherence to disclosure norms designed to protect investor interests and maintain market integrity.

Arunjyoti Bio Ventures Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI's depositories regulations. The filing, dated 13.04.2026, covers the quarter ended 31.03.2026 and confirms the company's adherence to prescribed compliance standards.

Regulatory Compliance Filing

The compliance certificate was filed under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018. P.B.N. Murthy, Whole-Time Director with DIN 01445523, signed and submitted the certificate to BSE Limited at P.J. Towers, Dalal Street, Mumbai.

Depository Participant Certificate

Venture Capital and Corporate Investments Private Limited, serving as the company's depository participant, issued a certificate dated 06.04.2026. The depository participant confirmed that no securities were received for dematerialization or rematerialization during the quarter ended 31.03.2026.

Company Information

Arunjyoti Bio Ventures Limited operates from its registered office at Door No.1-98/1/JSK/6F/604-B, 6th Floor, Jain Sadhguru Capital Park, Beside Image Garden, Madhapur, Shaikpet, Hyderabad – 500 081. The company maintains its listing compliance through regular regulatory filings and adherence to SEBI guidelines.

The submission of this compliance certificate demonstrates the company's commitment to maintaining transparency and regulatory compliance in its securities operations. The certificate serves as a formal declaration of the company's compliance status for the specified quarter, ensuring stakeholders are informed about the company's adherence to depositories regulations.